Is Vectus Biosystems Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Vectus Biosystems Ltd (VBS.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Vectus Biosystems Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Vectus Biosystems Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Vectus Biosystems Ltd?

Muslim investors may consider investing in Vectus Biosystems Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Vectus Biosystems Ltd classified as HALAL?

Musaffa determines the Shariah status of Vectus Biosystems Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Vectus Biosystems Ltd updated?

The Shariah compliance status of Vectus Biosystems Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Vectus Biosystems Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Vectus Biosystems Ltd?

You can check the latest Shariah compliance status of Vectus Biosystems Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

VBS.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: July 31, 2025

Report Source: 2025 2nd Quarter Report

Vectus Biosystems Ltd. Stock Analysis VBS.AX

Australia Health Care Nano Cap Report: Q2, 2025

Vectus Biosystems Ltd. is a drug discovery and development company, which engages in the treatment for fibrosis and high blood pressure, which includes therapeutics for diseases in the fibrotic market namely heart, kidney, and liver disease. The company is headquartered in Rosebery, New South Wales. The company went IPO on 2016-02-23. The firm focuses on medical research and development. The company is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market, namely heart, kidney, and liver diseases. Its compound, VB0004, focuses on treating the hardening of functional tissue and high blood pressure. The company also focuses on developing candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH) as well as pulmonary fibrotic diseases. The firm has also developed technology focused at improving the speed and accuracy of measuring the amount of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Accugen is a platform, developed by its wholly owned subsidiary, Accugen Pty Limited, comprising of reagents, and software that quantitate polymerase chain reaction (qPCR) reactions.

Key Statistics of Vectus Biosystems Ltd (VBS.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.11AUD0.13

Today's Open

AUD0.11

Volume

193.86K

P/E Ratio (TTM)

52 Week Range

AUD0.04AUD0.46

Market Cap

5.88M

Avg. Volume

24.28K

Dividend Yield

Financial Metrics & Statements of Vectus Biosystems Ltd (VBS.AX)

FAQ's for Vectus Biosystems Ltd (VBS.AX)

According to Musaffa’s Shariah screening methodology, Vectus Biosystems Ltd (VBS.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.